The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat.

Diabetes Obes Metab 2010 Jan 13;12(1):72-81. Epub 2009 Oct 13.

Institute of Immunopathology, Russian Academy of Natural Sciences, Moscow, Russia.

Aim: To investigate the effects of Xanthigen (brown marine algae fucoxanthin + pomegranate seed oil (PSO)) on body weight, body fat, liver lipids, and blood biochemistry; and Xanthigen and its individual components on resting energy expenditure (REE) in obese, non-diabetic female volunteers with non-alcoholic fatty liver disease (NAFLD) and normal liver fat (NLF) content.

Methods: Sixteen-week, double-blind, randomized, placebo-controlled study. Food record data, body composition, REE (only 41 volunteers with NAFLD) and blood sample analysis were assessed weekly for 16 weeks in 151 non-diabetic, obese premenopausal women with liver fat content above 11% (NAFLD) n = 113, and below 6.5% (NLF) n = 38.

Results: Xanthigen-600/2.4 mg (300 mg PSO + 300 mg brown seaweed extract containing 2.4 mg fucoxanthin) resulted in statistically significant reduction of body weight (5.5 +/- 1.4 kg NAFLD group and 4.9 +/- 1.2 kg NLF group, p < 0.05), waist circumference (NAFLD group only), body (3.5 +/- 1.9 kg NAFLD group, p < 0.001; 3.6 +/- 0.7 kg NLF group, p < 0.05) and liver fat content, liver enzymes (NAFLD group only), serum triglycerides and C-reactive protein. Weight loss and reduction in body and liver fat content occurred earlier in patients with NLF than in patients with NAFLD. Fucoxanthin (> 2.4 mg) and Xanthigen-400/1.6 mg (200 mg PSO + 200 mg brown seaweed extract containing 1.6 mg fucoxanthin) significantly increased REE in NAFLD subjects compared to placebo.

Conclusions: Xanthigen promoted weight loss, reduced body and liver fat content, and improved liver function tests in obese non-diabetic women. Xanthigen and Fucoxanthin also increased REE. This product may be considered a promising food supplement in the management of obesity.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1463-1326.2009.01132.xDOI Listing
January 2010
132 Reads

Article Mentions


Provided by Crossref Event Data
twitter
Twitter: MedicinewomanRD
December 25, 2017, 4:21 pm EST
wikipedia
Wikipedia: Fucoxanthin
June 11, 2017, 4:46 pm EST
wikipedia
Wikipedia: Fucoxantina
May 28, 2017, 3:02 am EST
wikipedia
Wikipedia: פוקוקסנטין
May 25, 2017, 6:40 pm EST

Publication Analysis

Top Keywords

liver fat
24
nafld group
16
fat content
16
liver
11
nafld
9
liver disease
8
+/- nlf
8
obese non-diabetic
8
body weight
8
normal liver
8
+/- nafld
8
fucoxanthin increased
8
reduction body
8
increased ree
8
extract fucoxanthin
8
brown seaweed
8
seaweed extract
8
nlf group
8
body liver
8
group 005
8

References

(Supplied by CrossRef)
Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hypertension in alcohol consumers and obese people
Ikai et al.
J Hum Hypertens 1995
Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
Ludwig et al.
Mayo Clin Proc 1980
Prognosis in nonalcoholic steatohepatitis
Propst et al.
Gastroenterology 1995
Nonalcoholic fatty liver disease and obesity
Salgado et al.
Acta Cir Bras 2006

Haugan et al.
1995

Similar Publications